ArticleFrontiers in medicine2026
An exploratory exome-wide machine learning analysis identifies candidate host gene signatures associated with Long COVID in a large admixed Brazilian cohort.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Genetic factors have been suggested as modifiers of vulnerability to postCOVID-19 sequelae, referred to as Long COVID (LC). We hypothesize that LC may involve central nervous system (CNS)-related mechanisms, influenced by neuroinflammatory, autoimmune, viral mechanisms, and genetic factors. In this work, we used whole-exome sequencing in conjunction with a machine learning-based prioritization framework to investigate the connection between LC and host genomic variation. Methods: Our patient group included 312 individuals previously infected with SARS-CoV-2 enrolled in two public hospitals of Vitoria city, Brazil, between November 2020 and July 2023. After rigorous quality control in accordance with reference guidelines, the exome data revealed 651,652 variants in our cohort. To rank candidate variants, a supervised machine learning framework combining Recursive Feature Elimination (RFE) and XGBoost was implemented. Five variants were found to be statistically significant after Benjamini-Hochberg false discovery rate (FDR) correction in subsequent logistic regression analyses that were adjusted for age, sex, and principal components of ancestry under an additive genetic model. Results: The variant at Discussion: Our findings do not support single-gene causal effects; rather, they are consistent with the notion that common variants may collaboratively influence inter-individual variations in LC manifestations within a more extensive polygenic framework. Clinical features such as fatigue, pain, anosmia, dysautonomia, and cognitive impairment may reflect interactions between host genomic background and clinical or demographic factors. Overall, this study provides a hypothesis-generating integrative framework for investigating host genetic contributions to LC in an underrepresented admixed population. Targeted functional studies are important to ascertain the biological significance and translational applicability of these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.